Address Confusion About Biosimilars

December 2018

You'll see a growing list of biosimilars.

Nivestym or Zarxio for Neupogen (filgrastim)...Fulphila for Neulasta (pegfilgrastim)...and Inflectra or Renflexis for Remicade (infliximab).

Biosimilars are also approved for Enbrel, Humira, Avastin, and others...but aren't available due to legal disputes or other issues.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Influenza Compare Xofluza to Tamiflu for Treating the Flu
Antithrombotics Don't Suggest Xarelto for Most Coronary or Peripheral Artery Disease Patients
Vaccines Consider Whether Gardasil 9 May Benefit Patients Over Age 26
Migraine Don't Jump to a CGRP Antagonist for Migraine Prophylaxis
Raynaud's Know Which Meds Worsen or Improve Raynaud's Phenomenon
Aspirin Don't Recommend Aspirin to Prevent Cancer
Supplements Be Ready for Questions About the Activated Charcoal "Health" Trend
Biosimilars Address Confusion About Biosimilars
Depression Weigh Antidepressant Options for Older Patients
Hyponatremia Stay Alert for Meds That May Lead to Low Sodium Levels
Pediatrics Prepare for Questions About Treating Croup
Med Safety Extinguish Issues With Meds That Can Catch Fire

Address Confusion About Biosimilars

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents